Logo image of AREB

AMERICAN REBEL HOLDINGS INC (AREB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AREB - US02919L7038 - Common Stock

0.9993 USD
+0.04 (+4.09%)
Last: 12/16/2025, 12:42:23 PM
Fundamental Rating

1

AREB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 82 industry peers in the Commercial Services & Supplies industry. AREB has a bad profitability rating. Also its financial health evaluation is rather negative. AREB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AREB had negative earnings in the past year.
In the past year AREB has reported a negative cash flow from operations.
In the past 5 years AREB always reported negative net income.
In the past 5 years AREB always reported negative operating cash flow.
AREB Yearly Net Income VS EBIT VS OCF VS FCFAREB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of AREB (-218.53%) is worse than 93.90% of its industry peers.
Industry RankSector Rank
ROA -218.53%
ROE N/A
ROIC N/A
ROA(3y)-101.11%
ROA(5y)-293.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AREB Yearly ROA, ROE, ROICAREB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

AREB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AREB Yearly Profit, Operating, Gross MarginsAREB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

0

2. Health

2.1 Basic Checks

AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AREB has more shares outstanding
AREB has less shares outstanding than it did 5 years ago.
AREB has a worse debt/assets ratio than last year.
AREB Yearly Shares OutstandingAREB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5K 10K 15K
AREB Yearly Total Debt VS Total AssetsAREB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

AREB has an Altman-Z score of -10.66. This is a bad value and indicates that AREB is not financially healthy and even has some risk of bankruptcy.
AREB's Altman-Z score of -10.66 is on the low side compared to the rest of the industry. AREB is outperformed by 89.02% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.66
ROIC/WACCN/A
WACC7.81%
AREB Yearly LT Debt VS Equity VS FCFAREB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.72 indicates that AREB may have some problems paying its short term obligations.
AREB has a worse Current ratio (0.72) than 82.93% of its industry peers.
A Quick Ratio of 0.49 indicates that AREB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.49, AREB is doing worse than 90.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.49
AREB Yearly Current Assets VS Current LiabilitesAREB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

3. Growth

3.1 Past

AREB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.24%, which is quite impressive.
The Revenue for AREB has decreased by -37.77% in the past year. This is quite bad
AREB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 84.10% yearly.
EPS 1Y (TTM)65.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.34%
Revenue 1Y (TTM)-37.77%
Revenue growth 3Y125.95%
Revenue growth 5Y84.1%
Sales Q2Q%-12.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREB Yearly Revenue VS EstimatesAREB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AREB Yearly EPS VS EstimatesAREB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -10K -20K -30K

0

4. Valuation

4.1 Price/Earnings Ratio

AREB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AREB Price Earnings VS Forward Price EarningsAREB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AREB Per share dataAREB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K -4K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AREB!.
Industry RankSector Rank
Dividend Yield 0%

AMERICAN REBEL HOLDINGS INC

NASDAQ:AREB (12/16/2025, 12:42:23 PM)

0.9993

+0.04 (+4.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-10 2025-11-10
Earnings (Next)04-07 2026-04-07
Inst Owners0.32%
Inst Owner Change65.64%
Ins Owners0.01%
Ins Owner Change-0.33%
Market Cap6.14M
Revenue(TTM)9.47M
Net Income(TTM)-32.85M
Analysts82.86
Price TargetN/A
Short Float %3.34%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4702.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS1.54
BVpS-0.51
TBVpS-0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -218.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-101.11%
ROA(5y)-293.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.33%
Cap/Sales 0.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.49
Altman-Z -10.66
F-Score2
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)15.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.77%
Revenue growth 3Y125.95%
Revenue growth 5Y84.1%
Sales Q2Q%-12.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.72%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAN REBEL HOLDINGS INC / AREB FAQ

What is the ChartMill fundamental rating of AMERICAN REBEL HOLDINGS INC (AREB) stock?

ChartMill assigns a fundamental rating of 1 / 10 to AREB.


What is the valuation status of AMERICAN REBEL HOLDINGS INC (AREB) stock?

ChartMill assigns a valuation rating of 0 / 10 to AMERICAN REBEL HOLDINGS INC (AREB). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN REBEL HOLDINGS INC?

AMERICAN REBEL HOLDINGS INC (AREB) has a profitability rating of 0 / 10.


How financially healthy is AMERICAN REBEL HOLDINGS INC?

The financial health rating of AMERICAN REBEL HOLDINGS INC (AREB) is 0 / 10.